Malaysia Medical Device (Designated Medical Device) Order 2026

Malaysia’s Medical Device (Designated Medical Device) Order 2026, issued under the Medical Device Act 2012 [Act 737], formally designates certain aesthetic devices as medical devices. Effective 1 June 2026, this regulatory update clarifies the legal status of medical lasers, HIFU devices, and liposuction systems, with direct implications for Malaysia medical device registration, compliance, and clinical use.

Key Updates Under the Medical Device (Designated Medical Device) Order 2026

The Order, made pursuant to Section 26 of the Medical Device Act 2012, empowers the Minister of Health to specify devices that must be regulated as medical devices due to their medical risk, tissue interaction, or invasive nature.

Under this Order, aesthetic devices commonly used in dermatology and cosmetic medicine are no longer treated as general beauty equipment and are now subject to full regulatory oversight by Malaysia’s Medical Device Authority (MDA).

Aesthetic Devices Designated as Medical Devices in Malaysia

1. Medical Laser Devices

The following medical lasers are designated as medical devices based on wavelength and biological effect:

• Alexandrite laser (756 nm)

• Diode laser (800 nm)

• Erbium YAG laser (2940 nm)

• Fractional CO₂ laser (10,600 nm)

• Nd:YAG laser (532 nm or 1064 nm)

• Pulse-dye laser (585 nm or 595 nm)

• Ruby laser (694 nm)

These devices are regulated when used for purposes including hair removal, pigmentation reduction, treatment of vascular lesions, scar reduction, tissue ablation, skin rejuvenation, and treatment of actinic keratosis, in accordance with the manufacturer’s intended use.

2. High-Intensity Focused Ultrasound (HIFU) Devices

HIFU devices are designated as medical devices in Malaysia due to their deep tissue penetration and physiological impact. Approved purposes include:

• Skin rejuvenation and lifting via collagen stimulation

• Fat reduction through adipocyte apoptosis or coagulative necrosis

• Pigmentation reduction

• Other aesthetic uses consistent with intended use

3. Liposuction Devices

Liposuction devices are explicitly designated as medical devices due to their invasive nature and are regulated for:

• Removal of localised adipose (fat) deposits

• Other aesthetic purposes determined by the manufacturer and consistent with intended use

Regulatory Impact on Manufacturers, Importers, and Clinics

The designation of these aesthetic devices as medical devices triggers key regulatory obligations under Act 737:

• Mandatory medical device registration with the MDA

• Compliance with conformity assessment procedures

• Alignment of marketing and labelling with approved intended use

• Use by appropriately trained and authorised personnel

Non-compliance may result in enforcement action under Malaysia’s medical device regulatory framework.

Key Dates and Compliance Actions

• Order made: 8 January 2026

• Effective date: 1 June 2026

Stakeholders should review device portfolios, confirm classification status, and ensure readiness for registration prior to enforcement.

Why This Matters for Malaysia’s Aesthetic Industry

This regulatory update reflects Malaysia’s continued alignment with international best practices in medical device regulation. By clearly designating high-risk aesthetic technologies as medical devices, the MDA strengthens patient safety, regulatory clarity, and accountability across the aesthetic and cosmetic medicine sector.

External Reference

• Medical Device Act 2012 [Act 737] – Ministry of Health Malaysia (official source)

Internal Reference

• MDA Malaysia Medical Device Registration

• Manufacturers can now generate an instant cost estimate across markets using Pure Global’s interactive Fee Calculator